Developer docs
API playgroundTry for free, no card

Search company profiles

exeltis germany

Full company profile

uuid02mjqy4

Namestring
exeltis germany
Legal namestring
Exeltis Germany GmbH
Websiteurl
exeltis.de
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Exeltis Germany GmbH is a pharmaceutical company headquartered in Ismaning, Germany, that commercializes originator and generic women's health products across the entire female life cycle from menarche to menopause. Founded in 2010 under the name Velvian, the company now markets more than 30 branded prescription and OTC products covering contraception (oral tablets, the GinoRing vaginal ring, emergency contraception, and the delayed-release Kelzy oral contraceptive), fertility and pregnancy (the Xonvea two-phase doxylamine/pyridoxine formulation for nausea, plus nutritional supplements Clavella, Velnatal, and FOLANDROL), menopause hormone therapy (FAMENITA micronized progesterone, DERMESTRIL transdermal patches, VELBIENNE), and urogenital/specialty care (DeflaGyn oxidative gel for HPV-associated cervical dysplasia, GELIFEND, FENIZOLAN, Pravidel), as well as endometriosis (ENDOVELLE) and PCOS hirsutism (Kelzy). Underlying technologies include novel drug-delivery architectures such as the sustained-release retard oral tablet and the two-phase release combination formulation, both classified as proprietary method architectures.

The company operates a B2B2C distribution model in which a field sales force (Außendienst) targets prescribing gynecologists in the outpatient sector, driving prescription pull-through to German pharmacies that dispense the majority of revenue (over 50% now derived from originator products). A secondary direct-to-consumer channel is operated through exeltis.de/shop, which uses ApoNow GmbH to route non-prescription and supplement orders to local pharmacies for fulfillment. Exeltis also operates the reflec:T, MEET & LEARN, and LEARN & PRACTISE digital continuing-education programs that deliver CME-certified women's health training to thousands of medical professionals annually, in cooperation with Sanabeo Medical News, Keck Media, and DocCheck.

Exeltis Germany is a wholly-owned subsidiary of the family-owned Insud Pharma Group, which employs more than 9,000 people across over 50 sites globally and encompasses API manufacturing (Chemo), generics (Xiromed), and biosimilars (mAbxience). The German subsidiary employs over 100 people across commercial, medical, sales, marketing, finance, HR, technical, and regulatory functions, and was reported by General Manager Jan Tangermann to have doubled revenue over approximately 2.5 years. Exeltis Germany serves the DACH region through offices in Ismaning (Germany) and Vienna (Austria).

Short descriptiontext

Exeltis Germany is a DACH-region pharmaceutical company specializing in women's health prescription and OTC products across contraception, fertility, pregnancy, menopause, and urogenital care, distributing through a gynecology field sales force, pharmacies, and a DTC e-commerce shop, with over 30 brands and a strategic pivot toward originator products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersIsmaning, Germany
HQ citystring
Ismaning
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, women's health, prescription medications, contraceptive products, gynecological medicines
Industry4 codes
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAIADAJ
Women’s Health (OTC Gynecologic)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Women's Health Pharmaceuticals
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Prescription pharmaceutical products
TypeOne Time License
Description

Exeltis generates the majority of its revenue from prescription (rezeptpflichtig) pharmaceutical products sold through pharmacies and prescribed by gynecologists. Over 50% of revenue now comes from originator/original products.

exeltis.de
2Over-the-counter (OTC) and pharmacy-exclusive products
TypeOne Time License
Description

Certain products such as Femke (emergency contraception) are available without prescription (rezeptfrei), while others like Clavella Classic are pharmacy-exclusive (apothekenexklusiv), sold directly through the Exeltis shop and dispensed via partner pharmacies.

exeltis.de
3Nutritional supplements
TypeOne Time License
Description

Products such as Velnatal (Baby Planning, Pregnancy & Lactation), Clavella (Classic and Premium), and FOLANDROL are sold as dietary supplements, available directly through the Exeltis shop e-commerce channel.

exeltis.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Infrastructure
Pricing details5 tiers
1Clavella Classic 30 sachets
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase via the Exeltis shop through partner pharmacies (ApoNow GmbH)

exeltis.de
2Clavella Premium 30 or 60 sachets
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase via the Exeltis shop through partner pharmacies

exeltis.de
3FOLANDROL 60 sachets
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase via the Exeltis shop through partner pharmacies

exeltis.de
4Velnatal Babyplanung 30 or 90 soft capsules
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase via the Exeltis shop through partner pharmacies

exeltis.de
5Velnatal Schwangerschaft + Stillzeit 30 or 90 soft capsules
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase via the Exeltis shop through partner pharmacies

exeltis.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Exeltis Germany distributes and markets a portfolio of pharmaceutical products focused on women's health across all life stages, spanning contraception, fertility and pregnancy, urogenital health, menopause, endometriosis, and PCOS-related indications. The company sells through pharmacies and gynecologists across the DACH region (Germany, Austria, Switzerland), supported by a field sales force, and operates the ApoNow online shop for OTC women's health products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 50% of revenue from originator/original products (shifted from generics-focused)
+3 more records
Product overview1 text field

Exeltis Germany is a pharmaceutical company specializing in women's health products across the entire female lifecycle from menarche to menopause and beyond. The portfolio includes over 30 branded products organized into six therapeutic areas: contraception (hormonal contraceptives including oral tablets like ASUMATE®, Evaluna®, Slinda®, Kelzy®; vaginal ring GinoRing®; emergency contraception Femke®), fertility and pregnancy (XONVEA® for pregnancy nausea, nutritional supplements Clavella® Classic/Premium, Velnatal® Babyplanung, Velnatal® Schwangerschaft + Stillzeit, FOLANDROL® for men), urogenital health and specialty care (DeflaGyn®, GELIFEND®, FENIZOLAN®, Agnolyt® MADAUS Tinktur, Pravidel®), endometriosis (ENDOVELLE®), hirsutism in PCOS (Kelzy®), and menopause hormone therapy (FAMENITA® micronized progesterone, DERMESTRIL® transdermal patches, VELBIENNE®). The company also provides healthcare professional services including the reflec:T continuing education platform with CME-certified webinars, MEET & LEARN training series, and LEARN & PRACTISE modules for practice staff.

Product and service10 records
1Contraception portfolio (oral tablets, vaginal rings, emergency contraception)
CategoryContraception
2Fertility and pregnancy product line
CategoryFertility and pregnancy
3Urogenital health products
CategoryUrogenital health
4Menopause product line
CategoryMenopause therapy
5Endometriosis treatment product line
CategoryEndometriosis therapy
6PCOS / hirsutism treatment product line
CategoryPCOS / hirsutism therapy
7GinoRing (vaginal contraceptive ring)
CategoryContraception
8Kelzy retard
CategoryWomen's health pharmaceuticals
9Xonvea two-phase
CategoryWomen's health pharmaceuticals
10Slinda 24/4
CategoryContraception
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1Sanabeo Medical News
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Sanabeo Medical News is the provider of CME-certified state-of-the-art training programs and is the core partner for Exeltis's reflec:T digital education initiative, which reaches thousands of medical professionals annually with product-neutral, practice-oriented continuing education in women's health.

exeltis.de
2Keck Media
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Keck Media provides the webinar platform for Exeltis's MEET & LEARN endocrine training series for gynecology practice teams. Webinars are free for participants and include a certificate of attendance.

exeltis.de
3Dr. med. Matthias Krick (MVZ Moers)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Dr. med. Matthias Krick from MVZ Moers collaborated with Exeltis to develop the LEARN & PRACTISE training series for medical assistants (MFAs) in gynecological practices, covering practice management, organization, patient communication, and quality management.

exeltis.de
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

ApoNow GmbH powers the pharmacy finder and fulfillment logistics for Exeltis's online shop. Patients can order supplements and OTC products for home delivery or same-day pharmacy pickup through the ApoNow platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

DocCheck provides the login and authentication system for Exeltis's Fachkreise (professional healthcare) portal. Per German Heilmittelwerbegesetz (HWG), certain website content is restricted to verified medical-pharmaceutical professionals. DocCheck verifies credentials before granting access.

Strategic tierMinorTypeOthersAnnounced on1993-01-01
Description

Mundo Sano is a family-run foundation founded in 1993 by Dr. Roberto Gold, dedicated to fighting neglected diseases and improving the lives of affected people. It is referenced on the Exeltis website as a shared commitment to global health improvement.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1977-01-01
Description

Insud Pharma Group is the family-owned parent company of Exeltis, founded in 1977 by biochemist Silvia Gold and physician Hugo Sigman. The Group encompasses the full pharmaceutical value chain including API development (Chemo), biotech/biosimilars (mAbxience), generics (Xiromed), and the Exeltis commercial unit. Exeltis is the global commercialization and distribution unit focused on women's health, endocrinology, and CNS. The Group employs over 9,000 people at more than 50 sites globally. Today led by Leandro and Lucas Sigman.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Chemo develops and manufactures pharmaceutical active ingredients (APIs), generic medicines, and novel galenic formulations. It is the scientific and technological backbone of the Insud Pharma Group, operating its own R&D departments for new molecules and innovative dosage forms, with over 60 manufacturing and research facilities globally and thousands of patents and patent applications.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Xiromed is the Insud Pharma Group's generics division, particularly active in Europe and the USA with its own regulatory and distribution units, complementing the portfolio with generic solutions across multiple indications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

mAbxience develops and produces biopharmaceutical active ingredients and biosimilars, focused on oncology and autoimmune diseases, with production facilities in Spain, Argentina, and the USA. Part of the Insud Pharma integrated network supporting Exeltis.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Jenapharm is the German women's health pharmaceutical subsidiary of Aspen Pharmacare, offering a comparable portfolio of hormonal contraceptives, HRT products, and gynecological treatments prescribed by gynecologists in Germany. Direct overlap with Exeltis on contraception (oral pills, vaginal rings) and menopause hormone therapy in the DACH region.

TypeDirect peer
Description

Organon is a global specialty women's health company spun out of Merck, with a comparable portfolio in contraception (e.g., NuvaRing), fertility, and menopause. Operates with a similar field sales model targeting gynecologists and is the most direct large-scale specialty peer to Exeltis's originator-focused strategy.

TypeBroad incumbent
Description

Bayer is a broad incumbent whose pharmaceutical division competes directly in contraception (Yasmin/YAZ, Mirena IUD), menopause, and gynecological care. It has substantially larger R&D, marketing budgets, and global reach, but only women's health is one of multiple therapeutic franchises.

TypeDirect peer
Description

Gedeon Richter is a European specialty pharmaceutical company with a strong women's health portfolio including contraception, fertility, and menopause products sold across Europe including Germany. Highly comparable originator and generics mix, with similar field-force distribution through pharmacies.

TypeDirect peer
Description

Theramex is a global specialty women's health company focused on contraception, menopause, and fertility, sold through prescription and OTC channels in Europe. Closely comparable to Exeltis in therapeutic focus, originator/specialty positioning, and reliance on the gynecologist prescriber channel.

TypeDirect peer
Description

Aristo Pharma is a German pharmaceutical company with a strong generics portfolio that overlaps directly with Exeltis's contraceptive pills, HRT, and gynecological generics. Direct competitor in pharmacy-channel generics pricing and prescriber relationships.

TypeBroad incumbent
Description

Stada is a German-based generic and specialty pharmaceutical company with significant DACH presence, including in women's health (e.g., contraceptive pills, HRT). It is a broader portfolio incumbent that competes across Exeltis's categories in Germany.

TypeBroad incumbent
Description

Hexal is the German generics arm of Sandoz, the global generics leader. It competes directly with Exeltis's contraceptive and HRT generics through pharmacy channels and statutory insurance reimbursement tenders in Germany.

TypeRegional player
Description

Dermapharm is a German pharmaceutical company with a strong portfolio in dermatology, gynecology, and hormonal products. It competes in overlapping DACH channels, particularly in prescription gynecological and dermatological products sold through pharmacies.

TypeBroad incumbent
Description

Sanofi operates a global women's health franchise (including menopause therapies and Dupixent in gynecological indications). It is a broad incumbent with substantially larger resources and competes with Exeltis in the gynecologist-prescribed specialty space.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

exeltis germany

Women's Health Pharmaceuticalsexeltis.de

Exeltis Germany is a DACH-region pharmaceutical company specializing in women's health prescription and OTC products across contraception, fertility, pregnancy, menopause, and urogenital care, distributing through a gynecology field sales force, pharmacies, and a DTC e-commerce shop, with over 30 brands and a strategic pivot toward originator products.

What exeltis germany does

Exeltis Germany GmbH is a pharmaceutical company headquartered in Ismaning, Germany, that commercializes originator and generic women's health products across the entire female life cycle from menarche to menopause. Founded in 2010 under the name Velvian, the company now markets more than 30 branded prescription and OTC products covering contraception (oral tablets, the GinoRing vaginal ring, emergency contraception, and the delayed-release Kelzy oral contraceptive), fertility and pregnancy (the Xonvea two-phase doxylamine/pyridoxine formulation for nausea, plus nutritional supplements Clavella, Velnatal, and FOLANDROL), menopause hormone therapy (FAMENITA micronized progesterone, DERMESTRIL transdermal patches, VELBIENNE), and urogenital/specialty care (DeflaGyn oxidative gel for HPV-associated cervical dysplasia, GELIFEND, FENIZOLAN, Pravidel), as well as endometriosis (ENDOVELLE) and PCOS hirsutism (Kelzy). Underlying technologies include novel drug-delivery architectures such as the sustained-release retard oral tablet and the two-phase release combination formulation, both classified as proprietary method architectures.

The company operates a B2B2C distribution model in which a field sales force (Außendienst) targets prescribing gynecologists in the outpatient sector, driving prescription pull-through to German pharmacies that dispense the majority of revenue (over 50% now derived from originator products). A secondary direct-to-consumer channel is operated through exeltis.de/shop, which uses ApoNow GmbH to route non-prescription and supplement orders to local pharmacies for fulfillment. Exeltis also operates the reflec:T, MEET & LEARN, and LEARN & PRACTISE digital continuing-education programs that deliver CME-certified women's health training to thousands of medical professionals annually, in cooperation with Sanabeo Medical News, Keck Media, and DocCheck.

Exeltis Germany is a wholly-owned subsidiary of the family-owned Insud Pharma Group, which employs more than 9,000 people across over 50 sites globally and encompasses API manufacturing (Chemo), generics (Xiromed), and biosimilars (mAbxience). The German subsidiary employs over 100 people across commercial, medical, sales, marketing, finance, HR, technical, and regulatory functions, and was reported by General Manager Jan Tangermann to have doubled revenue over approximately 2.5 years. Exeltis Germany serves the DACH region through offices in Ismaning (Germany) and Vienna (Austria).

exeltis germany firmographics

Firmographics
Name
exeltis germany
Legal name
Exeltis Germany GmbH
Website
https://exeltis.de
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
Exeltis Germany is a DACH-region pharmaceutical company specializing in women's health prescription and OTC products across contraception, fertility, pregnancy, menopause, and urogenital care, distributing through a gynecology field sales force, pharmacies, and a DTC e-commerce shop, with over 30 brands and a strategic pivot toward originator products.
Ownership category
akta.pro rank

exeltis germany industry classification

Industry
Product category
Women's Health Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAIADAJ
Women’s Health (OTC Gynecologic)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)

Keywords

  • Pharmaceutical products
  • Women's health
  • Prescription medications
  • Contraceptive products
  • Gynecological medicines

Where exeltis germany is headquartered

Location

Headquarters

HQ city
Ismaning
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

exeltis germany business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Prescription pharmaceutical products: Exeltis generates the majority of its revenue from prescription (rezeptpflichtig) pharmaceutical products sold through pharmacies and prescribed by gynecologists. Over 50% of revenue now comes from originator/original products.
  2. Over-the-counter (OTC) and pharmacy-exclusive products: Certain products such as Femke (emergency contraception) are available without prescription (rezeptfrei), while others like Clavella Classic are pharmacy-exclusive (apothekenexklusiv), sold directly through the Exeltis shop and dispensed via partner pharmacies.
  3. Nutritional supplements: Products such as Velnatal (Baby Planning, Pregnancy & Lactation), Clavella (Classic and Premium), and FOLANDROL are sold as dietary supplements, available directly through the Exeltis shop e-commerce channel.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goClavella Classic 30 sachets
Unit PricingPay-as-you-goClavella Premium 30 or 60 sachets
Unit PricingPay-as-you-goFOLANDROL 60 sachets
Unit PricingPay-as-you-goVelnatal Babyplanung 30 or 90 soft capsules
Unit PricingPay-as-you-goVelnatal Schwangerschaft + Stillzeit 30 or 90 soft capsules

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

exeltis germany product offering

Product offering

Core offering

Exeltis Germany distributes and markets a portfolio of pharmaceutical products focused on women's health across all life stages, spanning contraception, fertility and pregnancy, urogenital health, menopause, endometriosis, and PCOS-related indications. The company sells through pharmacies and gynecologists across the DACH region (Germany, Austria, Switzerland), supported by a field sales force, and operates the ApoNow online shop for OTC women's health products.

Product overview

Exeltis Germany is a pharmaceutical company specializing in women's health products across the entire female lifecycle from menarche to menopause and beyond. The portfolio includes over 30 branded products organized into six therapeutic areas: contraception (hormonal contraceptives including oral tablets like ASUMATE®, Evaluna®, Slinda®, Kelzy®; vaginal ring GinoRing®; emergency contraception Femke®), fertility and pregnancy (XONVEA® for pregnancy nausea, nutritional supplements Clavella® Classic/Premium, Velnatal® Babyplanung, Velnatal® Schwangerschaft + Stillzeit, FOLANDROL® for men), urogenital health and specialty care (DeflaGyn®, GELIFEND®, FENIZOLAN®, Agnolyt® MADAUS Tinktur, Pravidel®), endometriosis (ENDOVELLE®), hirsutism in PCOS (Kelzy®), and menopause hormone therapy (FAMENITA® micronized progesterone, DERMESTRIL® transdermal patches, VELBIENNE®). The company also provides healthcare professional services including the reflec:T continuing education platform with CME-certified webinars, MEET & LEARN training series, and LEARN & PRACTISE modules for practice staff.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contraception portfolio (oral tablets, vaginal rings, emergency contraception)
  • Fertility and pregnancy product line
  • Urogenital health products
  • Menopause product line
  • Endometriosis treatment product line
  • PCOS / hirsutism treatment product line
  • GinoRing (vaginal contraceptive ring)
  • Kelzy retard
  • Xonvea two-phase
  • Slinda 24/4

Quantifiable outcome

  • Over 50% of revenue from originator/original products (shifted from generics-focused)
  • +3 more outcomes

Companies that use exeltis germany

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles2 records

exeltis germany technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

exeltis germany partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Sanabeo Medical NewscoreStrategic or Co-development Partner · 1 January 2025Sanabeo Medical News is the provider of CME-certified state-of-the-art training programs and is the core partner for Exeltis's reflec:T digital education initiative, which reaches thousands of medical professionals annually with product-neutral, practice-oriented continuing education in women's health.
  • Keck MediacoreGTM or Marketing Partner · 1 January 2025Keck Media provides the webinar platform for Exeltis's MEET & LEARN endocrine training series for gynecology practice teams. Webinars are free for participants and include a certificate of attendance.
  • Dr. med. Matthias Krick (MVZ Moers)minorStrategic or Co-development Partner · 1 January 2025Dr. med. Matthias Krick from MVZ Moers collaborated with Exeltis to develop the LEARN & PRACTISE training series for medical assistants (MFAs) in gynecological practices, covering practice management, organization, patient communication, and quality management.
  • ApoNow GmbHminorChannel Partner/ Reseller/ Distributor · 1 January 2025ApoNow GmbH powers the pharmacy finder and fulfillment logistics for Exeltis's online shop. Patients can order supplements and OTC products for home delivery or same-day pharmacy pickup through the ApoNow platform.
  • DocCheck CommunitycoreTechnology or Integration · 1 January 2025DocCheck provides the login and authentication system for Exeltis's Fachkreise (professional healthcare) portal. Per German Heilmittelwerbegesetz (HWG), certain website content is restricted to verified medical-pharmaceutical professionals. DocCheck verifies credentials before granting access.
  • Mundo Sano FoundationminorOthers · 1 January 1993Mundo Sano is a family-run foundation founded in 1993 by Dr. Roberto Gold, dedicated to fighting neglected diseases and improving the lives of affected people. It is referenced on the Exeltis website as a shared commitment to global health improvement.
  • Insud Pharma Group (Parent Company)coreStrategic or Co-development Partner · 1 January 1977Insud Pharma Group is the family-owned parent company of Exeltis, founded in 1977 by biochemist Silvia Gold and physician Hugo Sigman. The Group encompasses the full pharmaceutical value chain including API development (Chemo), biotech/biosimilars (mAbxience), generics (Xiromed), and the Exeltis commercial unit. Exeltis is the global commercialization and distribution unit focused on women's health, endocrinology, and CNS. The Group employs over 9,000 people at more than 50 sites globally. Today led by Leandro and Lucas Sigman.
  • Chemo (Part of Insud Pharma Group)coreStrategic or Co-development PartnerChemo develops and manufactures pharmaceutical active ingredients (APIs), generic medicines, and novel galenic formulations. It is the scientific and technological backbone of the Insud Pharma Group, operating its own R&D departments for new molecules and innovative dosage forms, with over 60 manufacturing and research facilities globally and thousands of patents and patent applications.
  • Xiromed (Part of Insud Pharma Group)coreChannel Partner/ Reseller/ DistributorXiromed is the Insud Pharma Group's generics division, particularly active in Europe and the USA with its own regulatory and distribution units, complementing the portfolio with generic solutions across multiple indications.
  • mAbxience (Part of Insud Pharma Group)coreStrategic or Co-development PartnermAbxience develops and produces biopharmaceutical active ingredients and biosimilars, focused on oncology and autoimmune diseases, with production facilities in Spain, Argentina, and the USA. Part of the Insud Pharma integrated network supporting Exeltis.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

exeltis germany competitors and assessment

Company assessment

Direct peers

  • Jenapharm: Jenapharm is the German women's health pharmaceutical subsidiary of Aspen Pharmacare, offering a comparable portfolio of hormonal contraceptives, HRT products, and gynecological treatments prescribed by gynecologists in Germany. Direct overlap with Exeltis on contraception (oral pills, vaginal rings) and menopause hormone therapy in the DACH region.
  • Organon & Co. Organon is a global specialty women's health company spun out of Merck, with a comparable portfolio in contraception (e.g., NuvaRing), fertility, and menopause. Operates with a similar field sales model targeting gynecologists and is the most direct large-scale specialty peer to Exeltis's originator-focused strategy.
  • Gedeon Richter Pharma: Gedeon Richter is a European specialty pharmaceutical company with a strong women's health portfolio including contraception, fertility, and menopause products sold across Europe including Germany. Highly comparable originator and generics mix, with similar field-force distribution through pharmacies.
  • Theramex: Theramex is a global specialty women's health company focused on contraception, menopause, and fertility, sold through prescription and OTC channels in Europe. Closely comparable to Exeltis in therapeutic focus, originator/specialty positioning, and reliance on the gynecologist prescriber channel.
  • Aristo Pharma: Aristo Pharma is a German pharmaceutical company with a strong generics portfolio that overlaps directly with Exeltis's contraceptive pills, HRT, and gynecological generics. Direct competitor in pharmacy-channel generics pricing and prescriber relationships.

Broad incumbents

  • Bayer (Pharmaceuticals / Women's Health): Bayer is a broad incumbent whose pharmaceutical division competes directly in contraception (Yasmin/YAZ, Mirena IUD), menopause, and gynecological care. It has substantially larger R&D, marketing budgets, and global reach, but only women's health is one of multiple therapeutic franchises.
  • Stada Arzneimittel: Stada is a German-based generic and specialty pharmaceutical company with significant DACH presence, including in women's health (e.g., contraceptive pills, HRT). It is a broader portfolio incumbent that competes across Exeltis's categories in Germany.
  • Hexal (Sandoz): Hexal is the German generics arm of Sandoz, the global generics leader. It competes directly with Exeltis's contraceptive and HRT generics through pharmacy channels and statutory insurance reimbursement tenders in Germany.
  • Sanofi (Women's Health / HRT): Sanofi operates a global women's health franchise (including menopause therapies and Dupixent in gynecological indications). It is a broad incumbent with substantially larger resources and competes with Exeltis in the gynecologist-prescribed specialty space.

Regional players

  • Dermapharm Holding SE: Dermapharm is a German pharmaceutical company with a strong portfolio in dermatology, gynecology, and hormonal products. It competes in overlapping DACH channels, particularly in prescription gynecological and dermatological products sold through pharmacies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

exeltis germany social profiles

Digital presence

exeltis germany financial estimates

Financial estimate

Revenue estimate

Valuation estimate

exeltis germany leadership team

Management profile

Number of profiles

Profiles8 records

exeltis germany funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

exeltis germany M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about exeltis germany

What does exeltis germany do?

Exeltis Germany distributes and markets a portfolio of pharmaceutical products focused on women's health across all life stages, spanning contraception, fertility and pregnancy, urogenital health, menopause, endometriosis, and PCOS-related indications. The company sells through pharmacies and gynecologists across the DACH region (Germany, Austria, Switzerland), supported by a field sales force, and operates the ApoNow online shop for OTC women's health products.

Is exeltis germany a public or private company?

exeltis germany is a private company. It is classified as corporate owned and is currently operating.

When was exeltis germany founded?

exeltis germany was founded in 2010. It employs 51 to 100 people.

Where is exeltis germany based?

exeltis germany is headquartered in Ismaning, Germany, in the Europe region.

How does exeltis germany make money?

Three revenue lines are on record. Prescription pharmaceutical products are the primary driver. The others are over-the-counter (OTC) and pharmacy-exclusive products and nutritional supplements.

Who are exeltis germany's main competitors?

Direct peers on record are Jenapharm, Organon & Co., Gedeon Richter Pharma, Theramex and Aristo Pharma. Broad incumbents are Bayer (Pharmaceuticals / Women's Health), Stada Arzneimittel, Hexal (Sandoz) and Sanofi (Women's Health / HRT). Dermapharm Holding SE is listed as a regional player.

Does exeltis germany have an API?

No public API is recorded for exeltis germany.

What industry is exeltis germany in?

exeltis germany's product category is Women's Health Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health), with a secondary code of HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales